Online:
Visits:
Stories:
Profile image
By Money Morning (Reporter)
Contributor profile | More stories
Story Views

Now:
Last Hour:
Last 24 Hours:
Total:

This “Quick Doubler” Biotech Will Likely Disappoint

Thursday, March 16, 2017 2:09
% of readers think this story is Fact. Add your two cents.

(Before It's News)

Stroke kills an American every four minutes – more than 525,000 individuals each year – and nearly 300,000 more fall victim to its debilitating consequences.

The onset of symptoms signal a dire emergency. According to the National Stroke Association, they can include:

  • Sudden numbness or weakness of the face, arm or leg, especially on one side of the body;
  • Sudden confusion, trouble speaking or understanding;
  • Sudden trouble seeing or blurred vision in one or both eyes; and/or
  • Sudden trouble walking, dizziness, loss of balance or coordination.

There are two types of stroke: hemorrhagic and ischemic. The first results from a ruptured blood vessel in the brain, and the other from an inadequate blood supply, usually due to a blood clot blocking an artery that feeds the brain. 

The second variety, ischemic stroke, is by far the more common. Nearly nine out of 10 are of this type. And that’s fortunate, because an ischemic stroke could be relatively easy to prevent – provided you see it coming.

If you had the technology to find and map arterial blockages safely, simply, and quickly, you could intervene with a relatively simple medical procedure, clear the blockage, and bring down that enormous annual incidence of stroke to a much smaller number.

Does such a technology exist?

Currently, doctors can use an ultrasound machine to detect the presence of an occlusion (blockage) or stenosis (narrowing) in a carotid or cerebral artery, but the patient then has to undergo a CT scan or MRI for more definitive information.

It’s a complicated, drawn-out, and extremely expensive process, and you would think a single-step, cheaper technology might be a game changer – and represent a windfall for investors.

One micro-cap biotech in Vancouver, Canada, CVR Medical, is counting on exactly that with its new carotid stenotic scan (CSS) device.

The device is about to enter pivotal clinical trials, and after they’re completed, will go to the U.S. Food and Drug Administration (FDA) for marketing approval.

The CSS could save the government up to $34 billion a year, according to the CDC, and more importantly, hundreds of thousands of lives in the United States and around the world.

That’s great news for patients and their families. And it has proven a terrific opportunity for investors, too. Since the company’s IPO in November 2016, the stock is already up over 90%.

But here’s the thing. This device may not be the silver bullet it’s cracked up to be. And the stock isn’t, either.

I’m going to show you what’s really happening here and how to ultimately profit on this situation. It’s a great example of how independent research can save you a lot of money in the long run…

Tags: biotechnology

To get full access to all Money Morning content, click here

About Money Morning: Money Morning gives you access to a team of ten market experts with more than 250 years of combined investing experience – for free. Our experts – who have appeared on FOXBusiness, CNBC, NPR, and BloombergTV – deliver daily investing tips and stock picks, provide analysis with actions to take, and answer your biggest market questions. Our goal is to help our millions of e-newsletter subscribers and Moneymorning.com visitors become smarter, more confident investors.

Disclaimer: © 2017 Money Morning and Money Map Press. All Rights Reserved. Protected by copyright of the United States and international treaties. Any reproduction, copying, or redistribution (electronic or otherwise, including the world wide web), of content from this webpage, in whole or in part, is strictly prohibited without the express written permission of Money Morning. 16 W. Madison St. Baltimore, MD, 21201.

The post This “Quick Doubler” Biotech Will Likely Disappoint appeared first on Money Morning – We Make Investing Profitable.

Report abuse

Comments

Your Comments
Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

Top Stories
Recent Stories
 

Featured

 

Top Global

 

Top Alternative

 

Register

Newsletter

Email this story
Email this story

If you really want to ban this commenter, please write down the reason:

If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.